18,414 Shares in Option Care Health, Inc. (NASDAQ:OPCH) Purchased by Aquatic Capital Management LLC

Aquatic Capital Management LLC purchased a new position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 18,414 shares of the company's stock, valued at approximately $427,000.

A number of other hedge funds and other institutional investors have also modified their holdings of the business. Vanguard Group Inc. boosted its stake in shares of Option Care Health by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock worth $448,118,000 after acquiring an additional 75,313 shares in the last quarter. Wellington Management Group LLP grew its holdings in Option Care Health by 84.6% during the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after purchasing an additional 8,400,208 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in shares of Option Care Health by 17.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after buying an additional 591,042 shares during the last quarter. Norges Bank bought a new stake in shares of Option Care Health during the 4th quarter worth $60,219,000. Finally, Charles Schwab Investment Management Inc. grew its stake in Option Care Health by 6.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock valued at $58,235,000 after buying an additional 147,054 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Insider Activity at Option Care Health

In related news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now owns 44,974 shares in the company, valued at $1,495,835.24. This represents a 40.80 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. 0.64% of the stock is currently owned by corporate insiders.

Option Care Health Trading Down 0.4 %

NASDAQ:OPCH traded down $0.14 during trading hours on Monday, hitting $32.81. 2,237,241 shares of the stock were exchanged, compared to its average volume of 1,828,300. The company has a market capitalization of $5.37 billion, a P/E ratio of 27.57, a price-to-earnings-growth ratio of 2.30 and a beta of 0.76. The company has a quick ratio of 1.32, a current ratio of 1.73 and a debt-to-equity ratio of 0.77. The company's 50 day moving average is $33.34 and its two-hundred day moving average is $28.82. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last announced its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 EPS for the quarter, topping analysts' consensus estimates of $0.36 by $0.04. The firm had revenue of $1.33 billion during the quarter, compared to analyst estimates of $1.26 billion. Option Care Health had a return on equity of 15.30% and a net margin of 4.37%. The company's revenue was up 16.3% on a year-over-year basis. During the same period last year, the company earned $0.26 earnings per share. On average, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research analysts have commented on OPCH shares. JPMorgan Chase & Co. lifted their price target on Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research reaffirmed an "outperform" rating and issued a $38.00 target price on shares of Option Care Health in a research report on Wednesday, April 30th. JMP Securities reiterated a "market outperform" rating and set a $36.00 target price on shares of Option Care Health in a research report on Tuesday, April 22nd. Finally, UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price target for the stock from $38.00 to $40.00 in a research note on Wednesday, April 30th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat.com, Option Care Health presently has a consensus rating of "Moderate Buy" and an average target price of $35.50.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.